ABSTRACTS OF ARTICLES:1. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG; for the Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008 [Feb 13 Epub ahead of print] [cited Feb 22, 2008]
INTERESTING PUBLICATIONS WITH FREE ONLINE ACCESS:
50. Strus M, Jonczyk A, Gonet-Surowka A, Brzychczy-Wloch M, Stochel G, Kochan P, Heczko PB. Effect of hydrogen peroxide of bacterial origin on apoptosis and necrosis of gut mucosa epithelial cells as a possible pathomechanism of inflammatory bowel disease and cancer. J Physiol Pharmacol 2009; 60 (Suppl 6):55-60. [cited March 03, 2010]
49. Swidsinski A, Loening-Baucke V, Herber A. Mucosal flora in Crohn´s disease and ulcerative colitis - an overview. J Physiol Pharmacol 2009; 60 (Suppl 6):61-71. [cited March 03, 2010]
48. Strus M, Gosiewski T, Fyderek K, Wedrychowicz A, Kowalska-Duplaga K, Kochan P, Adamski P, Heczko PB. A role of hydrogen peroxide producing commensal bacteria present in colon of adolescents with inflammatory bowel disease in perpetuation of the inflammatory process. J Physiol Pharmacol 2009; 60 (Suppl 6):49-54. [cited March 03, 2010]
47. Konturek PC, Sliwowski Z, Koziel J, Ptak-Belowska A, Burnat G, Brzozowski T, Konturek SJ. Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress. J Physiol Pharmacol 2009; 60 (Suppl 6):41-48. [cited March 03, 2010]
46. Karczewska E, Wojtas I, Sito E, Trojanowska D, Budak A, Zwolinska-Wcislo M, Wilk A. Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. J Physiol Pharmacol 2009; 60 (Suppl 6):33-39. [cited March 03, 2010]
45. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R. Effects of probiotic and prebiotic on gastrointestinal motility in newborns. J Physiol Pharmacol 2009; 60 (Suppl 6):27-31. [cited March 03, 2010]
44. Conti C, Malacrino C, Mastromarino P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 2009; 60 (Suppl 6):19-26. [cited March 03, 2010]
43. Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009; 60 (Suppl 6):13-18. [cited March 03, 2010]
42. Bosscher D, Breynaert A, Pieters L, Hermans N. Food-based strategies to modulate the composition of the microbiota and their associated health effects. J Physiol Pharmacol 2009; 60 (Suppl 6):5-11. [cited March 03, 2010]
41. Kochan P, Strus M, Heczko PB. Are medical university students aware of probiotics? 5th PROBIOTICS, PREBIOTICS & NEW FOODS, 13-15 September 2009, Rome, Italy. (please right-click and select Save as... to download the poster) [cited September 29, 2009]
40. Ritter P, Kohler C, von Ah U. Evaluation of the passage of Lactobacillus gasseri K7 and bifidobacteria from the stomach to intestines using a single reactor model. BMC Microbiol 2009; 9:87. [cited June 02, 2009]
39. Pezzilli R. Chronic pancreatitis: maldigestion, intestinal ecology and intestinal inflammation. World J Gastroenterol 2009; 15:1673-1676. [cited June 02, 2009]
38. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009; 15:1554-1580. [cited June 02, 2009]
37. Liong MT. Roles of Probiotics and Prebiotics in Colon Cancer Prevention: Postulated Mechanisms and In-vivo Evidence. Int J Mol Sci 2008;9:854-863. [cited June 02, 2009]
36. Baron M. A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med 2009; 121:114-118. [cited June 02, 2009]
35. Hun L. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med 2009; 121:119-124. [cited June 02, 2009]
34. Lutgendorff F, Nijmeijer RM, Sandström PA, Trulsson LM, Magnusson KE, Timmerman HM, van Minnen LP, Rijkers GT, Gooszen HG, Akkermans LM, Söderholm JD. Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. PLoS ONE 2009; 4:e4512. Epub 2009 Feb 18. [cited June 02, 2009]
33. Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 2009; 9:35. [cited June 02, 2009]
32. Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS ONE 2009; 4:e4903. Epub 2009 Mar 20. [cited June 02, 2009]
31. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N, Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9:15. [cited June 02, 2009]
30. Hedge DD, Strain JD, Heins JR, Farver DK. New advances in the treatment of Clostridium difficile infection (CDI). Ther Clin Risk Manag 2008; 4:949-964. [cited June 02, 2009]
29. Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, Pati Y, Chinegwundoh F, Buchholz N. Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urol 2008; 24:139-144. [cited June 02, 2009]
28. Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshuis J, Le Mair T, Kaufmann P, de Paula JA, Fedorak R, Shanahan F, Sanders ME, Szajewska H. World Gastroenterology Organisation Practice Guideline Probiotics and prebiotics. World Gastroenterology Organisation, May 2008. [cited Jan 27, 2009]
27. Kochan P, Heczko PB. What do doctors-to-be know about probiotics? II EUROPEAN CONFERENCE ON PROBIOTICS AND THEIR APPLICATIONS, 15-17 October 2008, Cracow, Poland. (please right-click and select Save as... to download the poster) [cited Jan 27, 2009]
26. Kochan P, Bardowski J, Bielecka M, Heczko PB, Szajewska H. Etapy tworzenia wytycznych Polskiego Towarzystwa Probiotycznego i Prebiotycznego dotyczacych klinicznego zastosowania probiotykow. XXVI MEETING OF THE SOCIETY OF POLISH MICROBIOLOGISTS, 4-7 September 2008, Szczecin, Poland. (please right-click and select Save as... to download the poster) [cited Sep 07, 2008]
25. Kochan P, Strus M, Heczko PB. Will probiotics be banned for the severely immunocompromised? 3rd International Probiotic Conference 2008 (IPC2008): Probiotics for the 3rd Millennium, 4-7 June 2008, Hotel Bellevue, High Tatras, Slovakia. (please right-click and select Save as... to download the poster) [cited Jun 09, 2008]
24. Food Quality and Standards Service, Food and Agriculture Organization. Odprawa Techniczna FAO dotyczaca PREBIOTYKÓW. Kochan P. (ed.) Polskie Towarzystwo Probiotyczne i Prebiotyczne, Kraków 2008 (ISBN 978-83-926010-3-6) (click to open the on-line version)
